• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    2/8/22 3:52:59 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $NAII alert in real time by email
    SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 9 )*

                

    Natural Alternatives International Inc


    (Name of Issuer)

    Common Stock


    (Title of Class of Securities)

    638842302


    (CUSIP Number)

    December 31, 2021


    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X] Rule 13d-1(b)
    [ ] Rule 13d-1(c)
    [ ] Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)


    CUSIP No. 638842302

    1. NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

    Dimensional Fund Advisors LP
    30-0447847
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) [ ]
    (b) [X]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware Limited Partnership

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 517,264 ** see Note 1 **
    6. SHARED VOTING POWER 0
    7. SOLE DISPOSITIVE POWER 528,449 ** see Note 1 **
    8. SHARED DISPOSITIVE POWER 0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    528,449 ** see Note 1 **
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    8.3%
    12. TYPE OF REPORTING PERSON

    IA

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    


    Item 1.
    (a) Name of Issuer
    Natural Alternatives International Inc
    (b) Address of Issuer's Principal Executive Offices
    1185 Linda Vista Drive, San Marcos, CA 92078
    Item 2.
    (a) Name of Person Filing
    Dimensional Fund Advisors LP
    (b) Address of Principal Business Office or, if None, Residence
    6300 Bee Cave Road, Building One, Austin, TX 78746
    (c) Citizenship
    Delaware Limited Partnership
    (d) Title of Class of Securities
    Common Stock
    (e) CUSIP Number
    638842302
    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
    (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
    (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
    (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
    (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
    (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).
    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
    (a) Amount Beneficially Owned:
    528,449 ** see Note 1 **
    (b) Percent of Class:
    8.3%
    (c) Number of shares as to which such person has:
    (i) sole power to vote or to direct the vote 517,264 ** see Note 1 **
    (ii) shared power to vote or to direct the vote 0
    (iii) sole power to dispose or to direct the disposition of 528,449 ** see Note 1 **
    (iv) shared power to dispose or to direct the disposition of 0
    ** Note 1 ** Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the "Funds"). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, "Dimensional") may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds, and may be deemed to be the beneficial owner of the shares of the Issuer held by the Funds. However, all securities reported in this schedule are owned by the Funds. Dimensional disclaims beneficial ownership of such securities. In addition, the filing of this Schedule 13G shall not be construed as an admission that the reporting person or any of its affiliates is the beneficial owner of any securities covered by this Schedule 13G for any other purposes than Section 13(d) of the Securities Exchange Act of 1934.
    Item 5. Ownership of Five Percent or Less of Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    The Funds described in Note 1 above have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the securities held in their respective accounts. To the knowledge of Dimensional, the interest of any one such Fund does not exceed 5% of the class of securities. Dimensional Fund Advisors LP disclaims beneficial ownership of all such securities.
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Not Applicable
    Item 8. Identification and Classification of Members of the Group.

    Not Applicable. This schedule is not being filed pursuant to Rule 13d-1(b)(1)(ii)(J) or Rule 13d-1(d).
    Item 9. Notice of Dissolution of Group.

    Not Applicable
    Item 10. Certification.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dimensional Fund Advisors LP
    By: Dimensional Holdings Inc., General Partner
    By: /s/ Selwyn Notelovitz
    Date: February 14, 2022
    Name: Selwyn Notelovitz
    Title: Global Chief Compliance Officer

    Get the next $NAII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NAII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dunn Alan G was granted 8,000 shares, increasing direct ownership by 10% to 91,211 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/11/25 5:16:26 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Ramanathan Guru was granted 8,000 shares, increasing direct ownership by 36% to 30,000 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/11/25 5:15:28 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Matherly Laura Kay was granted 8,000 shares, increasing direct ownership by 31% to 34,000 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/11/25 5:15:06 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results

    CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $7.2 million, or ($1.20) per diluted share, on net sales of $33.9 million for the fourth quarter of fiscal year 2025 compared to a net loss of $1.9 million, or ($0.32) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2025 included non-recurring non-cash charges of $1.4 million related to the settlement of a litigation matter and a $4.8 million valuation allowance against our net deferred tax asse

    9/23/25 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company

    CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company ("Juice Plus+"), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets around the world. Mark A. LeDoux, NAI's CEO and Chairman of the Board, said, "Continuing our 30+ year relationship with JuicePlus+ reflects our shared commitment to delivering premium nutrit

    7/21/25 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank

    CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit facility with Wells Fargo Bank, NA ("Wells Fargo"). This amendment modifies the current facility extending the term of the agreement to December 31, 2026 and modifies the borrowing capacity to $10 million. Mark A. Le Doux, Chairman and Chief Executive Officer of NAI stated, "We are grateful for our long-standing relationship with Wells Fargo and we believe this amended credit facility is made possible by the strength of our balance sheet.

    6/23/25 4:15:43 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    SEC Filings

    View All

    SEC Form 10-K filed by Natural Alternatives International Inc.

    10-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    9/23/25 4:16:24 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    7/21/25 4:32:50 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    7/1/25 4:01:11 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Leadership Updates

    Live Leadership Updates

    View All

    Natural Alternatives International Appoints New VP of Global Sales

    CARLSBAD, Calif., July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth. Over the course of his 25 plus year career in the domestic and international nutritional supplement industry, Conti has established a proven track record of success in building new business within multiple markets. "Shan

    7/25/23 9:00:00 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    NATURAL ALTERNATIVES INTERNATIONAL APPOINTS AARON STARR VICE PRESIDENT FOR CARNOSYN® BRANDS

    CARLSBAD, Calif., April 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Aaron Starr has been promoted to Vice President of CarnoSyn® Brands. In his new role, Starr will be responsible for the leadership of business teams and for overseeing operational performance and the advancement of CarnoSyn® Brands. "I am pleased to announce Aaron Starr has been named Vice President of CarnoSyn® Brands," said Kenneth Wolf, President and Chief Operating Officer, Natural Alternatives International. "Aaron has been a valued member of our team for many year

    4/21/22 5:00:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Neptune Wellness Appoints Randy Weaver as Interim Chief Financial Officer and Retains Dr. Toni Rinow as Chief Operating Officer

    LAVAL, QC, Sept. 27, 2021 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced the appointment of Randy Weaver as Interim Chief Financial Officer while retaining Dr. Toni Rinow as Chief Operating Officer. Mr. Weaver joins Neptune as Interim Chief Financial Officer with a successful track record of leading numerous CPG companies as a senior executive, bringing the knowledge and e

    9/27/21 7:30:00 AM ET
    $NAII
    $NEPT
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $NAII
    Financials

    Live finance-specific insights

    View All

    Natural Alternatives International, Inc. Announces 2022 Q1 Results

    CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ -- -Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.51 per diluted share, on net sales of $38.3 million for the first quarter of fiscal year 2022 compared to net income of $2.3 million, or $0.35 per diluted share, in the first quarter of the prior fiscal year.  Net sales during the three months ended September 30, 2021 decreased $1.4 million, or 3.5%, to $38.3 million as compared to $39.7 million recorded in the comparable prior year period.  During the same period, private-label contract man

    11/9/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces 2021 Q3 and YTD Results

    CARLSBAD, Calif., May 13, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.9 million, or $0.30 per diluted share, on net sales of $46.3 million for the third quarter of fiscal year 2021 compared to a net loss of $4.0 million, or $0.61 per diluted share, in the third quarter of the prior fiscal year.  Our results for the third quarter of fiscal 2020 included the negative impact of a $4.3 million accounts receivable and inventory reserve related to a former customer, which was not repeated in the third quarter of fiscal 2021.  Net s

    5/13/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/13/24 10:37:08 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/9/24 9:59:14 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/5/24 8:25:38 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care